Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study

Authors

Keywords

Journal

Volume 137, Issue 4, Pages 1079-1090

Publisher

Elsevier BV

Online

2016-04-05

DOI

10.1016/j.jaci.2015.12.1318

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now